Worldwide Clinical Trials and Medidata Partner
Analysis based on 7 articles · First reported Apr 23, 2026 · Last updated Apr 23, 2026
The market is positively impacted by the strategic partnership between Worldwide Clinical Trials and Dassault Systèmes — Medidata Solutions, as it signifies advancements in clinical trial efficiency and data integrity through AI. This collaboration is expected to drive innovation in the biotechnology and pharmaceutical industries, potentially accelerating drug development and improving patient care.
Worldwide Clinical Trials, a global contract research organization, and Dassault Systèmes — Medidata Solutions, a Dassault Systèmes brand, have announced a strategic evolution of their partnership. Worldwide Clinical Trials is the first global CRO to implement Dassault Systèmes — Medidata Solutions Plus, gaining full access to Dassault Systèmes — Medidata Solutions's AI layer, including Dot, Dassault Systèmes — Medidata Solutions's virtual companion. This integration aims to enhance the precision, quality, and timelines of clinical trials by streamlining workflows from protocol design to study close-out. Alistair Macdonald, CEO of Worldwide Clinical Trials, and Anthony Costello, CEO of Dassault Systèmes — Medidata Solutions, both highlighted the significance of this partnership in defining new standards for clinical trial delivery and leveraging AI as a foundational force for business scaling.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard